. Global Pharma DrugAnalyst Database

DrugAnalyst Database

DRUGANALYST LTD
172 TOTTENHAM COURT RD
LONDON W1T 7NS

+44 20 3696 7500

Log In

Company
Sector
Drugs
Valuation
Changes
Share Prices
Portfolio
Get Access

European Pharma

Argenx
AstraZeneca
Bayer

Galapagos
Genmab
Glaxo

Grifols
Ipsen
Lundbeck

Merck KGaA
Novartis
Novo Nordisk

Roche
Sanofi
UCB

US Pharma

AbbVie
Alnylam
Amgen
Biogen
Biohaven
BioMarin

Bristol
Epizyme
Exelixis
Gilead
Horizon

Incyte
Ionis
Jazz
JnJ
Lilly

Merck
Moderna
Neurocrine
Pfizer
Regeneron

Sage
Seagen
Teva
Vertex
Viatris

Asia Pacific Pharma

Astellas
Chugai

CSL
Daiichi

Eisai

Shionogi

Takeda

Numbers only

Peer Comparison

Total Revenue
Pharma Sales
Trading Profit
Gross Margin
SG&A Margin
R&D Margin
TPMeR&D Margin
Trading Margin
Tax Rate
Net Income

Incremental Margin
Net Cash/Debt to Equity Ratios
Per Employee Metrics
Growth - CAGRs
Drug Sales Expectation Change
Core Adjustments
Net Debt / EBITDA Ratios
Dividend Yield
Revenue High/Low Analysis
Net Profit High/Low Analysis
Receivables Outstanding

Sector P&L

EU Major
US Major
Japanese
US Big Biotech

Price Performance

Sector Performance Charts

R&D

R&D Pipeline

Biggest Drugs
Biggest Pipeline Drugs
Growers
Decliners
Upgrades
Downgrades
High/Low Analysis
Drug List
US Exposure

Therapeutic Areas

Acid Disorders
ADHD
Alzheimer's
Asthma / COPD
Atopic Dermatitis
Breast Cancer
Chronic Dry Eye
Colorectal Cancer
COVID-19
Cystic Fibrosis
Depression
Dyslipidaemia
Haemophilia
Diabetes: All
HCV
HIV
Hypertension

Influenza
Lung Cancer
Lymphoma (NHL/CLL)
Melanoma
Migraine
Multiple Myeloma
Multiple Sclerosis
Opthalmic (AMD / RVO / DME)
Osteoporosis
Prostate Cancer
Psoriasis
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Thrombosis
Other...

Anti-PD(L)-1
Anti-PCSK-9
Anti-CD20
Anti-HER2
Anti-TNF
Anti-VEGF
Beta-amyloid
Insulin Analogues
DPP-4
GLP-1
SGLT2
JAK Inhibitors
PARP
Xa Inhibitors
Other...

Avastin
Enbrel
Herceptin
Humira
Mabthera
Remicade

Valuation Summary

Summary Sheet

Valuation Metrics

DA-NET
P/E
P/S
PEG
Consensus Target Prices

Other

Reporting Heatmap
US Flu Tracker

Custom Models

Your Client Rank:

Loading...

99

Updated 25-Jan-2022

Global Pharma Companies

| Home | Companies | Analysis | Testimonials | Downloads | Contact Us |
FCA registered and authorised
© 2022 DRUGANALYST LTD